Showing results (181-190 of 242) with videos related to
Sort By:
Pageof 25
Histology and Histopathology|December 6, 2019
Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysisFrancesca Sanguedolce, Luigi Cormio, Giuseppe Carrieri, et al.International Urology and Nephrology|April 2, 2024
Adequacy of prostate cancer prevention and screening recommendations provided by an artificial intelligence-powered large language modelGiuseppe Chiarelli, Alex Stephens, Marco Finati, et al.Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|March 18, 2020
Performance of prostate multiparametric MRI for prediction of prostate cancer extra-prostatic extension according to NCCN risk categories: implication for surgical planningUgo G Falagario, Ivan Jambor, Parita Ratnani, et al.The Prostate|October 28, 2024
Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohortsMarco Finati, Chase Morrison, Alex Stephens, et al.Frontiers in Oncology|June 7, 2021
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center StudySalvatore M Bruno, Ugo G Falagario, Nicola d'Altilia, et al.International Journal of Molecular Sciences|September 28, 2021
Prostate Cancer Radiogenomics-From Imaging to Molecular CharacterizationMatteo Ferro, Ottavio de Cobelli, Mihai Dorin Vartolomei, et al.The Journal of Urology|January 25, 2020
Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical ProstatectomyUgo G Falagario, Parita Ratnani, Anna Lantz, et al.Acta Radiologica Open|December 6, 2021
How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological databaseIvan Jambor, Alberto Martini, Ugo G Falagario, et al.European Urology Open Science|November 24, 2025
Refining Active Surveillance Eligibility in Intermediate-risk Non-muscle-invasive Bladder Cancer: The Impact of Time to First RecurrenceMarco Finati, Nicola Schiavone, Biagio Barone, et al.Cancer|May 28, 2024
Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohortShane A Tinsley, Marco Finati, Alex Stephens, et al.Pageof 25